Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 30 Sep 22 424B7 Prospectus with selling stockholder info
- 9 Sep 22 424B5 Prospectus supplement for primary offering
- 5 May 22 424B7 Prospectus with selling stockholder info
-
4 Apr 22 F-3ASR Automatic shelf registration (foreign)
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 3, 2022, with respect to the consolidated financial statements of Immunocore Holdings plc, incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
London, United Kingdom
April 4, 2022